ABIOMED, Inc.  

(Public, NASDAQ:ABMD)   Watch this stock  
Find more results for abmd
24.89
+0.07 (0.26%)
Aug 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.61 - 25.09
52 week 18.15 - 30.77
Open 24.86
Vol / Avg. 154,303.00/247,043.00
Mkt cap 1.00B
P/E 143.42
Div/yield     -
EPS 0.17
Shares 40.46M
Beta 1.72
Inst. own 117%
Nov 4, 2014
Q2 2015 Abiomed Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jul 31, 2014
Q1 2015 Abiomed, Inc. Earnings Release
Jul 31, 2014
Q1 2015 Abiomed Inc Earnings Call
Jun 11, 2014
Abiomed Inc at William Blair & Company LLC Growth Stock Conference
Jun 2, 2014
Abiomed, Inc. at Jefferies Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin -3.50% 4.00%
Operating margin -3.15% 4.55%
EBITD margin - 5.92%
Return on average assets -3.33% 3.92%
Return on average equity -4.05% 4.81%
Employees 511 -
CDP Score - -

Address

22 CHERRY HILL DR
DANVERS, MA 01923
United States - Map
+1-978-7775410 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ABIOMED, Inc., is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. In April 2014, the Company acquired exclusive license from collaboration partner Opsens Inc. In July 2014, Abiomed Inc acquired ECP Entwicklungsgesellschaft mbH (ECP), medical device company based in Berlin, Germany, and AIS GmbH Aachen Innovative Solutions through ECP.

Officers and directors

Michael R. Minogue Chairman of the Board, President, Chief Executive Officer
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert L. Bowen Chief Financial Officer, Vice President, Treasurer
Age: 64
Bio & Compensation  - Reuters
David M. Weber Chief Operating Officer
Age: 52
Bio & Compensation  - Reuters
William J. Bolt Senior Vice President - Global Product Operations
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Andrew J. Greenfield Vice President, General Manager - Global Marketing
Age: 41
Bio & Compensation  - Reuters
Michael G. Howley Vice President, General Manager - Global Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Dorothy E. Puhy Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Eric A. Rose M.D. Director
Age: 63
Bio & Compensation  - Reuters
W. Gerald Gerald Austen M.D. Independent Director
Age: 84
Bio & Compensation  - Reuters
Louis E. Lataif Independent Director
Age: 75
Bio & Compensation  - Reuters